|
|||||
|
|
3‐(7‐Azaindolyl)‐4‐indolylmaleimides as a novel class of mutant isocitrate dehydrogenase‐1 inhibitors: Design,synthesis, and biological evaluation |
|
| Authors: | Yuanyuan Hu Anhui Gao Honghui Liao Mengmeng Zhang Gaoya Xu Lixin Gao Lei Xu Yubo Zhou Jianrong Gao Qing Ye Jia Li |
| Affiliation: | 1. State Key Laboratory Breeding Base of Green Chemistry‐Synthesis Technology, Zhejiang University of Technology, Hangzhou, China;2. National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;3. The Second People Hospital of Xihu District, Hangzhou, China |
| Abstract: | |
| Keywords: | 2‐hydroxyglutaric acid 3‐(7‐azaindoyl)‐4‐indolylmaleimides isocitrate dehydrogenase 1 inhibitors tumor |